Metabolic Profile Abnormalities in Polycystic Ovary Syndrome: A Clinical Pathology Approach
Journal of Health, Wellness and Community Research · 12.05.2026 · 4 (9) · 1-11
DOI: 10.61919/rajekv62 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health, Wellness and Community Research, online erschienen am 12.05.2026. Verfasst von Zaib Un Nisa Mughal und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polycystic ovary syndrome is a common endocrine-metabolic disorder in reproductive-aged women and is associated with insulin resistance, dyslipidemia, impaired glucose regulation, and hepatic biochemical abnormalities that may increase long-term cardiometabolic risk.
Objective
This study aimed to compare fasting glucose, insulin resistance markers, lipid profile, and liver enzymes between women with polycystic ovary syndrome and age- and BMI-matched healthy controls attending tertiary-care hospitals in Sindh, Pakistan.
Methods
This case-control study included 150 women aged 18–40 years, comprising 75 women diagnosed with polycystic ovary syndrome using Rotterdam criteria and 75 healthy controls matched for age and body mass index. Clinical assessment, anthropometric measurements, and fasting biochemical testing were performed. Fasting glucose, fasting insulin, HOMA-IR, total cholesterol, triglycerides, HDL-C, LDL-C, alanine aminotransferase, and aspartate aminotransferase were compared between groups using appropriate statistical tests, and correlations between HOMA-IR and metabolic parameters were assessed.
Results
Women with polycystic ovary syndrome had higher fasting glucose than controls (104.5 ± 12.3 vs 89.2 ± 8.6 mg/dL; p < 0.001), fasting insulin (18.7 ± 5.6 vs 9.5 ± 3.2 μIU/mL; p < 0.001), and HOMA-IR (4.8 ± 1.4 vs 2.1 ± 0.7; p < 0.001). They also showed higher triglycerides, LDL-C, total cholesterol, ALT, and AST, with lower HDL-C. HOMA-IR correlated positively with triglycerides (r = 0.63), LDL-C (r = 0.42), and ALT (r = 0.38), and negatively with HDL-C (r = -0.51).
Conclusion
Women with polycystic ovary syndrome demonstrated a coordinated adverse metabolic profile involving insulin resistance, atherogenic dyslipidemia, and hepatic enzyme elevation despite comparable BMI. Routine metabolic profiling may support early risk identification and preventive management
Zitieren
APA
Mughal, Z. U. N., Nisa, S. U., Zai, J. A., Gillani, I. R., Khaliq, A., & Mazhar, N. (2026). Metabolic Profile Abnormalities in Polycystic Ovary Syndrome: A Clinical Pathology Approach. Journal of Health, Wellness and Community Research, 4(9), 1-11. https://doi.org/10.61919/rajekv62
Vancouver
Mughal ZUN, Nisa SU, Zai JA, Gillani IR, Khaliq A, Mazhar N. Metabolic Profile Abnormalities in Polycystic Ovary Syndrome: A Clinical Pathology Approach. Journal of Health, Wellness and Community Research. 2026;4(9):1-11. doi:10.61919/rajekv62
BibTeX
@article{Mughal2026,
author = {Mughal, Zaib Un Nisa and Nisa, Shams un and Zai, Jawaid Ahmed and Gillani, Iqra Riaz and Khaliq, Adil and Mazhar, Nimra},
title = {Metabolic Profile Abnormalities in Polycystic Ovary Syndrome: A Clinical Pathology Approach},
journal = {Journal of Health, Wellness and Community Research},
year = {2026},
volume = {4},
number = {9},
pages = {1--11},
doi = {10.61919/rajekv62}
}
EUVIMED